REFERENCES
- Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996; 171: 374–82.
- Nichols RL. Surgical infections: prevention and treatment, 1965 to 1995. Am J Surg 1996; 172: 68–74.
- Sandren P, Qvist H, Lingaas E, Giercksky KE. Significance of yeasts recovered from intraabdominal specimens in patients with gastrointestinal perforations [abstract no. 147]. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1996: 246.
- Sandren P, Nilsen K, Digranes A, Tjade T, Lassen J. Candida norvegensis: a fluconazole-resistant species. Antimicrob Agent Chemother 1997; 41: 1375–6.
- Nielsen H, Stenderup J. Invasive Candida norvegensis infection in immunocompromised patients. Scand J Infect Dis 1996; 28: 311–2.
- Nielsen H, Stenderup J, Brun B, Ladefoged J. Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1990; 28: 1664–5.
- Hood SV, Moore CB, Denning DW. Isolation of Candida norvegensis from clinical specimens: four case reports. Clin Infect Dis 1996; 23: 1185–7.
- Evans TG, Mayuer J, Cohen S, Classen D, Carroll K. Fluconazole failure in the treatment of invasive mycoses. J Infect Dis 1991; 164: 1232–5.
- Klepser ME, Lewis RE, Pfaller MA. Therapy of Candida infections: susceptibility testing, resistance, and therapeutic options. Ann Pharmacother 1998; 32: 1313–61.
- Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 1998; 27: 603–16.